Compare WVE & AHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | WVE | AHL |
|---|---|---|
| Founded | 2012 | 2002 |
| Country | Singapore | Bermuda |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.0B | 3.4B |
| IPO Year | 2015 | 2025 |
| Metric | WVE | AHL |
|---|---|---|
| Price | $13.40 | $37.28 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 16 | 8 |
| Target Price | $29.94 | ★ $39.44 |
| AVG Volume (30 Days) | ★ 4.0M | 367.8K |
| Earning Date | 03-03-2026 | 02-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 33.46 |
| EPS | N/A | ★ 6.60 |
| Revenue | $109,230,000.00 | ★ $3,191,700,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $16.20 | $7.73 |
| P/E Ratio | ★ N/A | $5.64 |
| Revenue Growth | ★ 103.75 | 5.65 |
| 52 Week Low | $5.28 | $27.05 |
| 52 Week High | $21.73 | $37.38 |
| Indicator | WVE | AHL |
|---|---|---|
| Relative Strength Index (RSI) | 43.21 | 61.52 |
| Support Level | $13.22 | $37.23 |
| Resistance Level | $14.51 | $37.38 |
| Average True Range (ATR) | 1.33 | 0.11 |
| MACD | -0.38 | -0.00 |
| Stochastic Oscillator | 3.18 | 65.62 |
WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.
Aspen Insurance Holdings Ltd is a Bermudian insurance and reinsurance company. Its principal business is marketing and underwriting specialty insurance and reinsurance regularly. It comprises underwriting operations, which include risk-bearing insurance and reinsurance operations; Investing activities, which support underwriting operations; and ACM operations, which earn underwriting, management, and performance fees. It has two segments: Aspen Insurance and Aspen Reinsurance. Aspen Insurance consists of property and casualty insurance, marine, aviation, and energy insurance, and financial and professional lines insurance. Aspen Reinsurance comprises property catastrophe reinsurance, other property reinsurance, casualty reinsurance, and specialty reinsurance.